Abstract: The netrin-1 protein displays anti-inflammatory activity in the liver and is an unexpected proinflammatory factor in CLD. The present invention provides for blocking or capturing netrin-1 in the liver for treating liver inflammation, and thus methods for treating liver inflammation. To perform this, the invention makes use of a polyclonal or monoclonal antibody specifically binding to netrin-1, including a series of humanized monoclonal antibodies.

Abstract: An enzymatic process and bioreactor use elongated structures to enhance CO2 capture treatments. The enzymatic process and bioreactor treat a fluid by catalyzing reaction (I) with carbonic anhydrase, CO2+H2OHCO?3+H+ (|) by feeding the fluid into a reaction zone wherein a plurality of elongated structures extend through the reaction zone. Each elongated structure supports a flowing liquid layer comprising droplets. Reaction (I) occurs within the flowing liquid layer in the presence of the carbonic anhydrase, to produce a gas stream and a liquid stream which are released. The process and bioreactor can be used in an absorption, desorption or combined treatment context.